Frontiers in Clinical Diabetes and Healthcare
Dapagliflozin & pioglitazone combination therapy in T2DM with or without MASLD - a systematic review and meta-analysis: PRO-2 study
ReviewInterventions
Papers by Dakshata Padhye
4 results
- ADA Scientific Sessions 2026 Abstract
Beyond Glycemic Control: Health-Related Quality-of-Life Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes
Study in peopleInterventions - ADA Scientific Sessions 2026 Abstract
Real-World Reduction in Albuminuria with Finerenone in Patients with Diabetic Chronic Kidney Disease
Study in peopleInterventions - ADA Scientific Sessions 2025 Abstract
Real-World Effectiveness of Finerenone in Indian Patients with Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
Study in peopleInterventions